Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C25H32Cl2O6 |
| Molecular Weight | 499.424 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(OC(OCC)[C@H](O)[C@H]1OCCC)[C@@H](COCC2=CC=C(Cl)C=C2)OCC3=CC=C(Cl)C=C3
InChI
InChIKey=UOYOWSGCMGEQHC-MSEXXDKFSA-N
InChI=1S/C25H32Cl2O6/c1-3-13-31-24-22(28)25(30-4-2)33-23(24)21(32-15-18-7-11-20(27)12-8-18)16-29-14-17-5-9-19(26)10-6-17/h5-12,21-25,28H,3-4,13-16H2,1-2H3/t21-,22-,23-,24-,25?/m1/s1
Clobenoside is a vasoprotective and anti-inflammatory agent. The drug was used for the topical treatment of chronic venous insufficiency and post-thrombotic syndrome. Clobenoside was also reportedly effective in treating traumatic edema through its inhibitory effects on histamine and/or kinins.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
65769
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
100000084280
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
249-940-5
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106001
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
2947
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
8427MP5VHD
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
DTXSID101043377
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
SUB06674MIG
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
C044699
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
683
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
29899-95-4
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
C77344
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | |||
|
m1077
Created by
admin on Fri Dec 15 16:03:03 GMT 2023 , Edited by admin on Fri Dec 15 16:03:03 GMT 2023
|
PRIMARY | Merck Index |
ACTIVE MOIETY
